Tongue Cancer Completed Phase Trials for Gefitinib (DB00317)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068497Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerTreatment